The pharma firm termed the retail price of Rs. 8.76 per tablet and Rs. 9.06 per tablet, respectively, excluding GST, as illegal and arbitrary. It also claimed that its formulations are "new drugs" approved by the Drugs Controller General of India (DCGI) and are exempt from the Drugs (Pricing and Control) Order, 2013.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment